Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450

被引：0
|
作者：
GENTEST Corporation, 6 Henshaw Street, Woburn, MA 01801, United States [1 ]
机构：
来源：
ANAL. BIOCHEM. | / 1卷 / 188-190期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Inhibition of cytochromes p450 by isoflavones
    Shebley, M
    Kim, H
    Roberts-Kirchhoff, ES
    FASEB JOURNAL, 2002, 16 (04): : A145 - A146
  • [32] Evaluation of possible inhibition of human liver drug metabolizing cytochromes P450 by two new acetylcholinesterase oxime-type reactivators
    Spicakova, Alena
    Anzenbacher, Pavel
    Liskova, Barbora
    Kuca, Kamil
    Fusek, Josef
    Anzenbacherova, Eva
    FOOD AND CHEMICAL TOXICOLOGY, 2016, 88 : 100 - 104
  • [33] Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat
    Hossain, Md Amin
    Tran, Timothy
    Chen, Tianmeng
    Mikus, Gerd
    Greenblatt, David J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (12) : 1786 - 1793
  • [34] Inhibition of human cytochromes P450 by components of Ginkgo biloba
    von Moltke, LL
    Weemhoff, JL
    Bedir, E
    Khan, IA
    Harmatz, JS
    Goldman, P
    Greenblatt, DJ
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (08) : 1039 - 1044
  • [35] Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids
    Salminen, Kaisa A.
    Meyer, Achim
    Jerabkova, Lenka
    Korhonen, Laura E.
    Rahnasto, Minna
    Juvonen, Risto O.
    Imming, Peter
    Raunio, Hannu
    PHYTOMEDICINE, 2011, 18 (06) : 533 - 538
  • [36] Regulation of drug-metabolizing human cytochrome P450s
    Monostory, Katalin
    Pascussi, Jean-Marc
    ACTA CHIMICA SLOVENICA, 2008, 55 (01) : 20 - 37
  • [37] Inhibition of drug-metabolizing enzyme activity in human hepatic cytochrome P450s by bisphenol A
    Niwa, T
    Tsutsui, M
    Kishimoto, K
    Yabusaki, Y
    Ishibashi, F
    Katagiri, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (04) : 498 - 501
  • [38] Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes
    Yurong Song
    Chenxi Li
    Guangzhi Liu
    Rui Liu
    Youwen Chen
    Wen Li
    Zhiwen Cao
    Baosheng Zhao
    Cheng Lu
    Yuanyan Liu
    Clinical Pharmacokinetics, 2021, 60 : 585 - 601
  • [39] Tesaglitazar (GALIDA™) does not inhibit the major drug-metabolizing cytochrome p450 enzymes
    Masimirembwa, C
    Rubin, K
    Andersson, T
    DIABETES, 2003, 52 : A126 - A126
  • [40] Structural genomics of human drug metabolizing P450 monooxygenases
    Johnson, E.
    FEBS JOURNAL, 2009, 276 : 25 - 25
12345